STAT October 4, 2023
Lev Facher

No medication is approved to treat addiction to either methamphetamine or cocaine. But the Food and Drug Administration is taking steps to fill that glaring gap in addiction medicine.

The agency on Wednesday issued draft guidance that encourages drug manufacturers to develop new treatments that could help treat addiction to meth, cocaine, or prescription stimulants. While the country’s current drug overdose crisis is largely driven by opioids, stimulant use has skyrocketed in recent years. An increasing share of drug deaths are now attributed to a combination of opioids and stimulants, or, in some cases, stimulants alone.

The FDA’s move comes amid increased recognition of the threat posed by stimulants, and the continued lack of medication options available for health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Mental Health, Provider
Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval
“Precision Med Has Evolved as Badly As I Expected” And Other Takeaways From Former FDA Commissioner At PMWC
FDA approves clinical trials for pig organ transplants
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
FDA Approves Third Tocilizumab Biosimilar

Share This Article